Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors as of March 31, 2022

Portfolio Holdings for Bain Capital Life Sciences Investors

Bain Capital Life Sciences Investors holds 34 positions in its portfolio as reported in the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Springworks Therapeutics (SWTX) 26.5 $273M 4.8M 56.44
Dynavax Technologies Corp Com New (DVAX) 8.9 $91M 8.4M 10.84
Arcutis Biotherapeutics (ARQT) 7.4 $77M 4.0M 19.26
Pharvaris N V (PHVS) 5.6 $58M 3.2M 18.13
Rapid Micro Biosystems Class A Com (RPID) 5.6 $57M 8.4M 6.79
Nuvalent Inc-a (NUVL) 4.6 $48M 3.4M 13.89
Crinetics Pharmaceuticals In (CRNX) 4.3 $45M 2.0M 21.95
Eqrx 4.0 $41M 10M 4.13
C4 Therapeutics Com Stk (CCCC) 3.9 $40M 1.6M 24.26
Amylyx Pharmaceuticals (AMLX) 3.4 $35M 2.8M 12.85
Mersana Therapeutics 2.5 $26M 6.5M 3.99
2seventy Bio Common Stock 2.3 $24M 1.4M 17.06
Aptinyx 2.0 $20M 8.9M 2.27
Xilio Therapeutics (XLO) 1.9 $20M 2.8M 7.07
Nurix Therapeutics (NRIX) 1.7 $18M 1.3M 14.01
Atea Pharmaceuticals (AVIR) 1.7 $18M 2.5M 7.22
Savara (SVRA) 1.5 $15M 12M 1.31
Tango Therapeutics (TNGX) 1.4 $15M 1.9M 7.58
Marinus Pharmaceuticals Com New 1.3 $13M 1.4M 9.35
Research Alliance Corp Ii Com Cl A 0.9 $9.8M 1.0M 9.76
Solid Biosciences 0.9 $9.5M 7.9M 1.20
Annexon (ANNX) 0.9 $8.8M 3.2M 2.73
Adagio Therapeutics (IVVD) 0.9 $8.8M 1.9M 4.56
Nautilus Biotechnology (NAUT) 0.8 $8.7M 2.0M 4.34
Syros Pharmaceuticals 0.7 $7.5M 6.3M 1.19
Arya Sciences Acqu Corp Iv Cl A (ARYD) 0.7 $6.9M 700k 9.80
Aeglea Biotherapeutics 0.6 $6.5M 2.8M 2.30
X4 Pharmaceuticals 0.5 $5.3M 3.0M 1.75
Panacea Acquisition Corp Ii Cl A Shs 0.5 $4.9M 500k 9.75
Arya Sciences Acquisitn Corp Class A Ord Shs 0.5 $4.9M 500k 9.71
Bcls Acquisition Corp Com Cl A 0.5 $4.8M 488k 9.87
Omega Alpha Spac Cl A 0.4 $3.9M 400k 9.82
Frazier Lifesciences Acqu Unit 12/09/2025 0.3 $3.0M 300k 9.99
Jiya Acquisition Corp Com Cl A 0.3 $2.9M 300k 9.83